QuidelOrtho Shares Drop on Carlyle's Secondary Offering
Shares of QuidelOrtho fell after the company said Carlyle Group was selling 8.26 million of its shares in an underwritten secondary offering. The stock was down 7.3% at $35.75 in premarket trading on ...
Target’s stock rocked after triple-miss earnings report amid ‘unique’ challenges
Target’s stock set to suffer worst day in more than two years after profit, revenue, comparable sales and the outlook were ...
S&P 500 bounces as stocks’ bull-market cycle seen potentially speeding up in 2025
The S&P 500 has bounced from its drop last week, a decline that had eroded its U.S. election bump without knocking the index ...
Traders trim Bank of England rate cut bets after U.K. inflation rebounds
The chances of another rate cut this year by the Bank of England has diminished after data showed an acceleration in the pace of Britain’s inflation last month.
Here are the numbers to watch when Nvidia reports earnings
Analysts tracked by FactSet expect Nvidia to post 75 cents in adjusted earnings per share for the fiscal third quarter, up from 40 cents a year before. The FactSet consensus calls for $33.2 billion in ...
Mortgage rates are near 7%, but buyers are making a comeback
Applications for mortgages in the latest week rose in spite of the 30-year rate inching up for the fourth week in a row to ...
Delta Air Lines sees opportunity in the “premium consumer” as it lays out long-term ...
Delta Air Lines Inc. DAL on Wednesday reiterated its fourth-quarter financial outlook as the carrier laid out long-term goals as part of its investor day. Delta said two-thirds of millennials are ...
Sage Therapeutics Shares Slide Premarket After Dalzanemdor Fails Again
Sage Therapeutics shares tumbled in premarket trading Wednesday after the biopharmaceutical company threw in the towel on dalzanemdor following the drug candidate's latest study failure. Sage shares, ...
Pfizer Gets European Approval of Hympavzi Hemophilia Drug
Pfizer said the green light makes Hympavzi the first once-weekly subcutaneous treatment in the European Union for people with severe hemophilia B and the first to be administered via a pre-filled pen ...
Pfizer names oncology chief Chris Boshoff as new chief scientific officer
Pfizer Inc. PFE named oncology chief Chris Boshoff as its new chief scientific officer on Wednesday, replacing Mikael Dolsten starting Jan. 1. The drug company had been searching for a new chief ...
As Nvidia reports, here’s the history of what happens next after ten giant stocks outperform
The fund manager AllianceBernstein looked at periods where the top 10 stocks dominated over the last three decades.
Sage Therapeutics’ stock slides after trial of Huntington’s Disease treatment fails and ...
Sage Therapeutics Inc.’s stock SAGE fell 18% early Wednesday, after the company said a mid-stage trial of a treatment for cognitive impairment associated with Huntington’s Disease failed to meet its ...